Skyhawk Therapeutics · 1 day ago
Senior Manager, Regulatory Project Management and Operations
Skyhawk Therapeutics is a biotechnology company focused on regulatory project management and operations. They are seeking a Senior Manager to lead the planning, coordination, and delivery of regulatory submissions to global health authorities, ensuring submission readiness and compliance across teams.
BiotechnologyTherapeutics
Responsibilities
Lead end-to-end submission planning for investigational and marketing applications
Assess submission risks and develop mitigation plans to ensure on-time delivery
Partner with Regulatory Lead to define submission strategy, timelines, and deliverables
Manage content planning, authoring assignments, and cross-functional review cycles
Oversee the compilation, formatting, and publishing of regulatory documents in compliance with global eCTD requirements
Act as the operational hub for regulatory submissions, facilitating communication across Regulatory, Clinical, Nonclinical, CMC, Program Management, and other functional teams
Drive submission team meetings, track progress, and mitigate risks
Establish clear roles, responsibilities, and timelines for team members
Manage interactions with external partners to ensure high-quality, timely filing
Evaluate vendor performance and implement process improvements as needed
Qualification
Required
Bachelor's degree in a scientific discipline
7+ years of regulatory submissions experience within the biotechnology or pharmaceutical industry
Proven track record managing major submissions (e.g., IND/CTA, NDA/BLA/MAA)
Strong project management skills, with the ability to lead complex, cross-functional workstreams
In-depth knowledge of eCTD structure, global submission requirements, and electronic publishing systems
Excellent communication, organization, and attention to detail
Company
Skyhawk Therapeutics
Skyhawk Therapeutics is a provvider of small molecule therapeutics designed to offer therapies that correct RNA expression.
Funding
Current Stage
Growth StageTotal Funding
$181.2MKey Investors
FidelityGood Growth Capital
2021-09-14Series Unknown· $133M
2019-01-01Series A
2018-06-15Series A· $40M
Recent News
Precedence Research
2025-11-05
Company data provided by crunchbase